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ABSTRACT
Prediabetes is associated with sugar-sweetened beverages and sugar-rich processed foods. High sugar intake (HSI), 
which is represented as save dose, may silently alter the glycemic control. The present study investigated the effect of 
HSI and Tiliacora triandra (TT21) leaf extract on the glycemic control in mice. Eighteen male ICR mice were divided into 
three groups of Control-HSI, HSI-TT300 and HSI-TT600 that received 4 weeks of 30% glucose with a vehicle of T. triandra 
leaf extract 300 and 600 mg/kg, respectively. The blood glucose, serum insulin, glucose clearance, liver and muscle 
glycogen contents and tissue oxidative status were evaluated. The results showed that HSI increased the blood glucose 
(w2 and w3: p<0.05) and serum insulin levels (w3 and w4: p<0.05) with glucose intolerance (w4: 30, 60 and 90 min, 
p<0.05). T. triandra leaf extract reduced the blood glucose and serum insulin and increased the glycogen content in 
the liver and muscle tissues (p<0.05). We concluded that HSI silently induced an alteration of the glycemic control in 
the normal mice, and the T. triandra leaf extract nurtured the glycemic control in the HSI mice by lowering the blood 
glucose and serum insulin and increasing the liver and muscle glycogen contents, which indicated an involvement of 
peripheral insulin sensitivity.
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ABSTRAK
Pra-diabetes telah dikaitkan dengan pengambilan minuman manis dan makanan yang kaya dengan gula. Pengambilan 
gula tinggi (HSI) yang dikenali sebagai dos simpanan mungkin secara perlahan mengubah kawalan glisemik. 
Penyelidikan ini mengkaji kesan HSI dan ekstrak daun Tiliacora triandra (TT21) terhadap kawalan glisemik pada 
tikus. Lapan belas ekor tikus ICR jantan telah dibahagikan kepada 3 kumpulan, iaitu kawalan-HSI, HSI-TT300 dan HSI-
TT600 yang menerima 30% glukosa selama 4 minggu dengan ekstrak daun T. triandra 300 dan 600 mg/kg sebagai 
pembawa. Glukosa darah, serum insulin, pelepasan glukosa, kandungan glikogen pada hepar dan otot serta status 
oksidatif tisu telah dinilai. Hasil kajian menunjukkan bahawa HSI meningkatkan glukosa darah (w2 dan w3: p<0.05) 
dan tahap insulin serum (w3 dan w4: p<0.05) dengan intoleransi glukosa (w4: 30, 60 dan 90 min, p<0.05). Ekstrak 
daun T. triandra mengurangkan glukosa darah, insulin serum dan peningkatan kandungan glikogen dalam tisu hepar 
dan otot (p<0.05). Berdasarkan keputusan kajian, kesimpulan bahawa HSI secara perlahan mendorong perubahan 
kawalan glisemik pada tikus normal dan ekstrak daun T. triandra mengawal kawalan glisemik dalam tikus HSI dengan 
menurunkan glukosa darah, insulin serum dan peningkatan kandungan glikogen pada hepar dan otot yang menunjukkan 
penglibatan kepekaan insulin periferi.
Kata kunci: Kawalan glisemik; metabolisme glukosa; pelepasan glukosa; pengambilan gula yang tinggi; Tiliacora triandra
INTRODUCTION
The worldwide increase of metabolic disease prevalence 
is found in both developing and developed countries 
(Osei-Yeboah et al. 2017). In the Asia-Pacific region, 
the rapid increase in prevalence has been from 11.9% to 
37.1% (Ranasinghe et al. 2017). A preference for sugar-
sweetened beverages and sugar-rich processed foods 
has increased dramatically and is regarded as the major 
risk for metabolic complications (Benetti et al. 2013), 
for instance metabolic syndromes, the complex disorder 
that refers to the clustering of central obesity, insulin 
resistance, impaired glucose tolerance, hypertension 
and dyslipidemia (Moreno-Fernandez et al. 2018). 
Dysregulation in the mechanisms implicated in glucose 
homeostasis can cause acute or chronic hyperglycemia 
and plays a major role in a variety of cell function 
deteriorations (Marcovecchio et al. 2011). Interestingly, 
prediabetes, a condition with abnormal high glucose 
concentrations below the cutoff for a diabetic diagnosis, 
is indicated in metabolic impairments (Succurro et al. 
2009). Prolonged systemic high glucose concentrations 
result in a large number of organ and tissue damages. 
The major deteriorative mediator is the reactive oxygen 
species (ROS), which is a result of a variety of metabolic 
1990 
pathways. An increase of the glucose flux through the 
polyol pathways, increase of the advanced glycosylation 
end product (AGEs) formations and activation of their 
receptors, activation of the PKC isoforms, over-activity 
of the hexosamine pathways, and a decrease in the 
antioxidant defenses are indicated as the mechanisms 
of glucose toxicity (Fiorentino et al. 2013; Kawahito et 
al. 2009). ROS directly alters proteins, lipids, DNA and 
cellular transduction signaling pathways, which lead 
to irreversible oxidative modifications. Alteration of 
protein expression caused by ROS, such as the mitogen 
activated protein kinases (MAPKs), NF-kB, hypoxia 
induced factor I (HIF-I), and activator protein I (AP-I), 
has been reported (Shah & Channon 2004). High glucose 
concentrations also aggravate endothelial cell dysfunction 
and is characterized by a reduction of nitric oxide (NO) 
production, hemodynamic deregulation, overproduction 
of growth factors, impaired fibrinolytic ability and 
enhanced permeability of the cell. These are found in 
both the macrovascular and microvascular and increase 
cardiovascular risks (Popov 2010). 
 Prevention of metabolic complications by the safest 
and most cost-effective option is dietary intervention with 
a lifestyle change impacting consumption. The studies 
have emphasized the use of food-derived compounds, 
natural ingredients, medicinal plants and herbs in 
metabolic balance and the prevention of diseases (Craig 
1999; Yamaki et al. 2016). Preventive therapy with 
medicinal plants, along with omitting sugar-sweetened 
beverages and sugar-rich processed food, has gained 
attention nowadays. Maintenance and balance of the body 
metabolisms by using dietary intervention helps prolong 
cell function, increase cell viability and strengthen 
against the attack of disease. There are many plants that 
have medicinal properties and may be a benefit to use 
for dietary intervention (Durmuskahya & Özturk 2013). 
Medicinal plants are mostly flavonoid-rich and have many 
bioactivities, including anti-inflammation, antioxidant, 
anti-diabetic and anticancer (Boonyawee et al. 2017). 
Tiliacora triandra leaves are used as an ingredient in 
Thai food have many benefits of traditional medicine. It 
is used to treat pyretic, malaria, inflammation, alcohol 
toxicities, diabetes, and oxidants (Phunchango et al. 2015; 
Sanya et al. 2012). The neuroprotective effect of the T. 
triandra leaf extract against ischemia-reperfusion injury 
has recently been reported (Thong-asa et al. 2017b). There 
are no acute or sub-chronic toxicological indications with 
this plant extract (Sireeratawong et al. 2008). As reported 
with the hypoglycemic activity in streptozotocin-induced 
diabetic rats of T. triandra (Katisart & Rattana 2017), it 
is interesting to assess the effect of the T. triandra leaf 
extract on the glycemic control, especially in prediabetes-
prone conditions associated with our common with sugar-
sweetened diets. Therefore, the present study aimed to 
investigate the effect of a chronic high sugar intake (HSI) 
and the modulatory effect of T. triandra leaf extract on 
the glycemic control in mice.
MATERIALS AND METHODS
ANIMALS
A total of 18 male ICR mice of 12-weeks of age were 
obtained from the National Laboratory Animal Centre, 
Mahidol University, Salaya, Nakornprathom, Thailand. 
They were housed individually in standard-sized cages at a 
well-controlled room temperature (24± 2oC) and humidity 
(55± 10%) with a 12 h/12 h light-dark cycle. 
PLANT EXTRACT
The ethanolic extract from the leaves of T. triandra was 
provided by the Animal Toxicology and Physiology 
Specialty Research Unit (ATPSRU) in the form of a green 
powder (TT21). Total phenolic and flavonoid contents of 
the extract were 340.21 mg GAE/g and 231.29 mg QE/g, 
respectively (Thong-asa et al. 2017b). 
EXPERIMENTAL PROTOCOL
The experimental protocol was approved by the Animal 
Ethics Committee, Kasetsart University Research and 
Development Institute (KURDI), Kasetsart University, 
Bangkok, Thailand (ID#ACKU04459). First of all, the 
data from all mice were collected as a baseline, i.e. body 
weight, blood glucose level, serum insulin level, and an oral 
glucose tolerance test (OGTT). 24 h later, all animals were 
fed with a 30% glucose in drink water as the high sugar 
intake (HSI) and standard food (082G) (Ehsanifard et al. 
2017). Mice were divided into three groups with six mice 
of each: Control-HSI, HSI-TT300 and HSI-TT600. Animals 
in the Control-HSI group received only the vehicle (10% 
Tween 80). Animals in HSI-TT300 and HSI-600 received the 
T. triandra leaf extract 300 and 600 mg/kg, respectively 
(Thong-asa & Laisangunngam 2018; Thong-Asa et al. 
2017a). Administrations were given continuously for 4 
weeks. The body weight and a blood draw from the tail 
vein were collected every week. Animals were sacrificed 
at the fourth week, and organ tissues were collected for 
biochemical analysis of the oxidative status and glycogen 
content.
ORAL GLUCOSE TOLERANCE TEST
After 6 h of fasting, all mice were subjected to an OGTT 
by gavage with glucose 2 g/kg of body weight. Blood 
was collected from the tail vein at the time of 0, 30, 90 
and 120 min after the glucose challenge to determine the 
blood glucose level by using the Easy G blood glucose 
monitoring system (Nagy & Einwallner 2018). 
SERUM INSULIN DETERMINATION
After blood collection, the blood was allowed to clot for 
15-30 min at room temperature. The clot was removed by 
centrifuging at 1, 000-2, 000g for 10 min in a refrigerated 
centrifuge, and the supernatant was collected as serum. 
The serum insulin levels were measured by an enzyme 
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immunoassay (Mouse ELISA kits, EZRMI-13K, Merck, 
Millipore).
BIOCHEMICAL ANALYSIS
The organ tissues of the brain, liver, heart, lung, stomach, 
kidney, and testes were collected for biochemical analysis 
of the total protein (Lowry et al. 1951), calcium (Spare 
1964), malondialdehyde (MDA), superoxide dismutase 
(SOD), and catalase (CAT) and for indexing the organ 
oxidative status (Sakamula & Thong-Asa 2018). 
PERIODIC ACID SCHIFF METHOD (PAS)
The liver and muscle tissues were processed for the PAS 
assessment of the glycogen content. Briefly, tissues were 
processed by embedding in paraffin and cutting into 
5 μm with a microtome. Five slides from each animal 
were selected. Tissue sections were processed in distilled 
water, treated with periodic acid for 5 min followed by 
distilled water, incubated with Schiff’s reagent for 15 
min and washed in running tap water for 10 min. Tissue 
sections were then rinsed in increasing concentrations 
of alcohol (70, 80, 95 and 100%), cleared in xylene and 
mounted as usual. Non-overlapping images in 5 regions 
of each slide were used. Image analysis for the liver and 
muscle glycogen was PAS positive area with diastase 
subtraction and represented as % area of PAS positive 
using NIH Image J.
STATISTICAL ANALYSIS
Data analysis using one-way analysis of variance (ANOVA) 
followed by Fisher’s PLSD post hoc test with p<0.05 was 
accepted.
RESULTS AND DISCUSSION
Four weeks of HSI did not induce significant changes of 
body weight and glucose intake. The highest blood glucose 
level was in the Control-HSI with a significant difference 
from the HSI-TT600 at the second and third week of HSI 
(p<0.05, Figure 1(b)). The significant difference of blood 
glucose levels between the Control-HSI and HSI-TT300 were 
found later at the third week of HSI (p<0.05, Figure 1(d)). 
Serum insulin in the Control-HSI group was increased from 
the third week of HSI, and a significant difference was found 
at the third and fourth week of HSI when compared to HSI-
TT600 (p<0.05, Figure 1(d)). The organ tissues’ oxidative 
status determined by calcium, MDA, SOD and CAT levels 
were not different among the tissues (Table 1). 
 The oral glucose tolerance test clearly indicated an 
alteration of the glycemic control in the chronic HSI mice. 
The baseline OGTT showed no difference in the glucose 
TABLE 1. Biochemical analysis of organ tissues oxidative status
Organs / groups Calcium(mEq/L)
MDA
(μM/mg protein)
SOD
(U/mg protein)
CAT
(U/mg protein)
Brain
Control-HSI
HSI-TT300
HSI-TT600
1.381±0.091
1.106±0.111
1.575±0.055
0.317±0.024
0.318±0.035
0.305±0.001
0.083±0.003
0.091±0.011
0.054±0.003
5.502±3.105
3.660±1.805
1.989±1.105
Liver
Control-HSI
HSI-TT300
HSI-TT600
2.299±0.489
2.778±0.196
2.079±0.406
0.270±0.040
0.358±0.053
0.386±0.067
0.055±0.021
0.053±0.023
0.026±0.007
8.460±1.148
6.772±1.602
4.855±1.140
Lung
Control-HSI
HSI-TT300
HSI-TT600
2.268±0.274
1.937±0.219
1.901±0.186
0.194±0.064
0.246±0.031
0.180±0.156
0.062±0.013
0.061±0.022
0.059±0.014
5.579±2.144
7.953±2.728
6.954±1.644
Heart
Control-HSI
HSI-TT300
HSI-TT600
1.631±0.212
1.713±0.099
1.820±0.146
0.291±0.094
0.158±0.056
0.210±0.147
0.040±0.012
0.042±0.007
0.036±0.015
3.813±1.988
3.573±1.687
4.212±1.112
Kidney
Control-HSI
HSI-TT300
HSI-TT600
2.498±0.131
1.952±0.159
1.758±1.146
0.061±0.003
0.043±0.033
0.069±0.017
0.054±0.016
0.053±0.018
0.057±0.005
7.571±0.914
9.713±3.282
6.058±1.458
Stomach
Control-HSI
HSI-TT300
HSI-TT600
1.713±0.121
1.962±0.210
1.855±0.137
0.028±0.003
0.071±0.008
0.152±0.072
0.074±0.008
0.069±0.007
0.072±0.003
3.534±0.863
3.363±0.988
5.698±0.579
Testis
Control-HSI
HSI-TT300
HSI-TT600
1.698±0.212
2.064±0.188
2.135±0.362
0.245±0.080
0.021±0.015
0.143±0.083
0.052±0.017
0.035±0.100
0.039±0.011
3.198±0.688
4.615±1.892
5.891±1.657
1992 
FIGURE 1. Body weight (a), blood glucose (b), glucose intake (c), serum insulin (d), oral glucose tolerance test (OGTT) 
before high sugar intake (HSI) (e), and OGTT 4 weeks after HIS (f). # indicates significant difference compare between 
Control-HSI and HSI-TT300. * indicates significant difference compare between Control-HSI and HSI-TT600
tolerance (Figure 1(e)) in all mice, while the fourth week 
of HSI represented a significant glucose intolerance in the 
Control-HSI group (p<0.05, Figure 1(f)). The T. triandra 
leaf extract significantly prevented an alteration of the 
glycemic control in HSI-TT300 and HSI-TT600 (p<0.05, 
Figure 1(f)). The significant difference was found at 30, 
60 and 90 min after the glucose challenge.
 The glycogen contents in the liver and muscle showed 
the same trend of increase by the T. triandra treated groups, 
and the high dose T. triandra treated group (HSI-TT600) 
showed a significant increase in the glycogen content in 
the liver and muscle tissues compared with Control-HSI 
(p<0.05, Figures 2-3). 
 Prediabetes prone, which is represented by a chronic 
increase of blood glucose levels but does not reach the 
diabetic diagnosis, is associated with sugar-sweetened 
beverages and sugar-rich processed foods. Chronic high 
concentrations of glucose in the blood can lead to an 
alteration of glycemic control in normal mice. We found 
that the HSI mice showed an alteration of glycemic control 
represented by glucose intolerance after 4 weeks of high 
glucose intake. Biochemical analysis of the organ tissues 
did not depict significant oxidative stress in the HSI mice. 
However, the blood glucose level and serum insulin 
were increased since the second and third week of HSI, 
respectively. This is a sign of insulin resistance that occurs 
in prediabetes. Glycemic controls are the maintaining 
of normal blood glucose range with neuroendocrine 
controlling of glucose metabolism. This consist of the 
balancing of glucose absorption from the gut, tissue 
utilization and the endogenous production of glucose 
(Kawahito et al. 2009). The present study found a lower 
glycogen content in the liver and muscle tissues in HSI 
mice than the T. triandra treated mice. Both low and high 
doses of T. triandra leaf extract exhibited an increase of 
glycogen storage in the liver and muscle tissues, though 
the significant difference was found only in the high dose. 
These implicated an alteration of the glycemic control in 
HSI mice can be prevented by T. triandra leaf extract. The 
study in streptozotocin-induced diabetic rats has found 
that T. triandra extract can reduce the elevated blood 
glucose, serum insulin, serum leptin, serum monocyte 
chemoattractant protein-1 (MCP-1), serum tumor necrosis 
factor (TNF)-alpha, serum MDA and triglyceride (TG) and 
indicate antioxidant and hypoglycemic activities of T. 
triandra leaf extract (Katisart & Rattana 2017). The blood 
glucose level was lowered together with the high preference 
of glucose intake in the T. triandra treated mice. This may 
involve a bitter taste of the extract that induces a preference 
to the glucose. Higher glucose preference in the T. triandra 
treated groups did not induce an increase of blood glucose 
levels and serum insulin when compared to the Control-HSI 
group, and alteration of the glycemic control appeared at the 
fourth week of his was not found in T. triandra treated mice. 
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FIGURE 2. Histological illustration of mice liver with PAS staining, 400× of magnification with 50 μm 
bars, cv = central vein. Histogram shows relative glycogen content represented by the percentage of 
PAS positive (% area). *indicates significant difference from Control-HSI
FIGURE 3. Histological illustration of mice muscle (biceps brachii), 400× of magnification with PAS 
staining with 50 μm bars. Histogram shows relative glycogen content represented by the percentage of 
PAS positive (% area). *indicates significant difference from Control-HSI
 Maintenance of the glycemic control is associated 
with the glycogen content in the liver and muscle tissues 
in the present study. Although the glycogen content in 
the liver is indicated as a major source of glucose in the 
glycemic control rather than in muscles (Kasuga et al. 
2003), the present study found a higher level of glycogen 
content in both the liver and muscle tissues in the T. 
triandra treated mice. Glycogen/glucose homeostasis 
is mainly regulated by two key enzymes, glycogen 
phosphorylase (GP) and glycogen synthase (GS). The key 
enzyme for glycogen breakdown is GP, which converts 
glycogen into glucose-1-phosphase and can be inhibited 
by flavonoids (Jakobs et al. 2006). High amounts of 
flavonoid content in the T. triandra leaf extract (Thong-
asa et al. 2017b) may have an inhibitory effect on GP and 
results in a high glycogen content in the T. triandra treated 
mice. In addition, flavonoids have been found to increase 
the glucokinase level that promotes glycogen synthesis 
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(Chen et al. 2015), this may facilitate glycogen storage 
in the T. triandra treated mice as well.
 The liver and skeletal muscle glycogen contents are 
reduced in type 2 diabetes (Shulman et al. 1990), in mice 
the muscle glycogen content is only about 10% compared 
to human muscle (Hribal et al. 2002). A greater effect on 
glucose tolerance of liver glycogen reduction than dose of 
muscle are indicated (Kasuga et al. 2003). In the present 
study, the maintenance of blood glucose in the T. triandra 
treated mice may involve the increase of peripheral insulin 
sensitivity. A reported indicated the increase of serum 
adiponectin in T. triandra extract treated mice (Naowaboot 
& Chularojmontri 2017). Augmentation of adiponectin 
in systemic circulation is associated with the increase of 
peripheral insulin sensitivity (Pajvani & Scherer 2003). 
Besides glycogen storage and the release of glucose 
from the liver in blood glucose control, the intestinal 
absorption is also involved. Interference of the intestinal 
absorption of glucose is found on plant fibers and flavonoid 
consumptions. A report indicated the intestinal facilitated 
glucose transporter recognizes a variety of flavonoids, 
and GLUT2, which is responsible for the glucose transport, 
is inhibited by dose dependent flavonoids as well (Chen 
et al. 2007). Therefore, flavonoid-rich T. triandra leaf 
extract maintains glucose homeostasis via the reduction 
of glycogen breakdown, promotion of glycogen synthesis, 
and increased insulin sensitivity (Vinayagam & Xu 2015). 
A high preference of glucose intake with the lowest blood 
glucose level and serum insulin, as well as the highest 
glycogen content that were found in HIS with the high dose 
T. triandra treated mice indicated a nurturing effect of T. 
triandra on the glycemic control, involving improvement 
of glucose clearance, inhibition of glycogen breakdown, 
promoting of glycogen synthesis, inhibition of glucose 
intestinal absorption, and increased peripheral insulin 
sensitivity. 
 Further studies are needed for confirmation of cellular 
and molecular level effects of T. triandra extract on the 
glycemic control mechanism. 
CONCLUSION
Effect of the T. triandra leaf extract on the glycemic control 
involves improvement of glucose clearance, inhibition of 
glycogen breakdown, promotion of glycogen synthesis, 
inhibition of glucose intestinal absorption, and increased 
peripheral insulin sensitivity. 
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